Increased cerebrospinal fluid and plasma apoE glycosylation is associated with reduced levels of Alzheimer’s disease biomarkers
Abstract The apolipoprotein E (APOE) ε4 allele is the strongest genetic risk factor for late-onset Alzheimer’s disease (AD). ApoE is glycosylated with an O-linked Core-1 sialylated glycan at several sites; however, the impact and function of this glycosylation on AD biomarkers remain unclear. We exa...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
BMC
2025-07-01
|
| Schriftenreihe: | Alzheimer’s Research & Therapy |
| Schlagworte: | |
| Online-Zugang: | https://doi.org/10.1186/s13195-025-01795-7 |
| Tags: |
Keine Tags, Fügen Sie das erste Tag hinzu!
|
